JP2025513593A5 - - Google Patents

Info

Publication number
JP2025513593A5
JP2025513593A5 JP2024563065A JP2024563065A JP2025513593A5 JP 2025513593 A5 JP2025513593 A5 JP 2025513593A5 JP 2024563065 A JP2024563065 A JP 2024563065A JP 2024563065 A JP2024563065 A JP 2024563065A JP 2025513593 A5 JP2025513593 A5 JP 2025513593A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
acid sequence
aforementioned
cdr3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024563065A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025513593A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/090822 external-priority patent/WO2023208034A1/en
Publication of JP2025513593A publication Critical patent/JP2025513593A/ja
Publication of JP2025513593A5 publication Critical patent/JP2025513593A5/ja
Pending legal-status Critical Current

Links

JP2024563065A 2022-04-26 2023-04-26 抗ｂ７－ｈ３抗体およびその使用 Pending JP2025513593A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2022089391 2022-04-26
CNPCT/CN2022/089391 2022-04-26
PCT/CN2023/090822 WO2023208034A1 (en) 2022-04-26 2023-04-26 Anti-b7-h3 antibodies and uses thereof

Publications (2)

Publication Number Publication Date
JP2025513593A JP2025513593A (ja) 2025-04-24
JP2025513593A5 true JP2025513593A5 (cg-RX-API-DMAC10.html) 2026-05-11

Family

ID=88517776

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024563065A Pending JP2025513593A (ja) 2022-04-26 2023-04-26 抗ｂ７－ｈ３抗体およびその使用

Country Status (5)

Country Link
US (1) US20250313632A1 (cg-RX-API-DMAC10.html)
EP (1) EP4514853A4 (cg-RX-API-DMAC10.html)
JP (1) JP2025513593A (cg-RX-API-DMAC10.html)
CN (1) CN119451988B (cg-RX-API-DMAC10.html)
WO (1) WO2023208034A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120225226A (zh) * 2023-10-25 2025-06-27 上海美雅珂生物技术有限责任公司 B7-h3抗体药物偶联物及其应用
WO2025245264A1 (en) * 2024-05-21 2025-11-27 Briapro Therapeutics Corp. Anti-b7-h3 antibodies and methods of use thereof
WO2026057014A1 (zh) * 2024-09-13 2026-03-19 江苏恒瑞医药股份有限公司 抗b7-h3抗体及其医药用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS61828B1 (sr) * 2016-06-08 2021-06-30 Abbvie Inc Anti-b7-h3 antitela i antitelske konjugacije lekova
CN109843927B (zh) * 2017-03-06 2022-06-21 江苏恒瑞医药股份有限公司 抗b7-h3抗体、其抗原结合片段及其医药用途
CN110305213B (zh) * 2018-11-09 2023-03-10 泰州复旦张江药业有限公司 一种抗b7-h3抗体及其制备方法、其偶联物和应用
WO2020094120A1 (zh) * 2018-11-09 2020-05-14 上海复旦张江生物医药股份有限公司 一种抗b7-h3抗体及其制备方法、其偶联物和应用
EP3883970A4 (en) * 2018-11-22 2022-03-30 Suzhou Kanova Biopharmaceutical Co., Ltd. ANTI-B7-H3 ANTIBODIES
CN109912718B (zh) * 2019-03-20 2020-12-11 北京善科生物科技有限公司 B7-h3抗原结合结构域的分离的结合蛋白、核酸、载体、car-t细胞及其应用
CN113527487A (zh) * 2020-04-22 2021-10-22 复星凯特生物科技有限公司 抗人b7-h3的单克隆抗体及其应用
CN111944050B (zh) * 2020-08-19 2022-05-13 苏州普乐康医药科技有限公司 一种抗b7-h3抗体及其应用
WO2022117040A1 (zh) * 2020-12-02 2022-06-09 迈威(上海)生物科技股份有限公司 抗人b7-h3抗体及其应用

Similar Documents

Publication Publication Date Title
JP2024537323A5 (cg-RX-API-DMAC10.html)
Hong et al. Chemoenzymatic synthesis of a rhamnose‐functionalized bispecific nanobody as a bispecific antibody mimic for cancer immunotherapy
JP2023511774A5 (cg-RX-API-DMAC10.html)
EP3645742B1 (en) Anti-ror1 antibodies and methods of making and using thereof
JP2023549537A5 (cg-RX-API-DMAC10.html)
JP2023535073A5 (cg-RX-API-DMAC10.html)
JP2022553922A5 (cg-RX-API-DMAC10.html)
JP2022513420A5 (cg-RX-API-DMAC10.html)
JP2022533418A5 (cg-RX-API-DMAC10.html)
JP2017532952A5 (cg-RX-API-DMAC10.html)
RU2020113027A (ru) Axl-специфичные антитела и их применения
RU2020103344A (ru) Конъюгаты антител с лекарственными средствами, характеризующиеся высокой in vivo переносимостью
CN114502591A (zh) 靶向bcma的抗体、双特异性抗体及其用途
HRP20120701T1 (hr) Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1
JP2024501894A5 (cg-RX-API-DMAC10.html)
JP2024001073A5 (cg-RX-API-DMAC10.html)
JP2023531185A5 (cg-RX-API-DMAC10.html)
CN117024592B (zh) 抗b7h3抗体及其用途
CN118076387A (zh) 靶向表达cdh17的肿瘤的多特异性抗体及其制备和使用方法
JP2020534012A5 (cg-RX-API-DMAC10.html)
JP2024504390A5 (cg-RX-API-DMAC10.html)
JP2023544143A5 (cg-RX-API-DMAC10.html)
JP7738914B2 (ja) ＴｒｉＡｘ抗体の組成、その製造方法及び使用方法
CN115279791A (zh) 靶向her2的抗原结合构建体及用途
JP2025506248A5 (cg-RX-API-DMAC10.html)